These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7821172

  • 1. Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia.
    Birkeland KI, Torjesen PA, Eriksson J, Vaaler S, Groop L.
    Diabetes Care; 1994 Nov; 17(11):1307-10. PubMed ID: 7821172
    [Abstract] [Full Text] [Related]

  • 2. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [Abstract] [Full Text] [Related]

  • 3. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients.
    Coifman R, Dalbosco IS, Russo EM, Moisés RS.
    Braz J Med Biol Res; 1999 Jan; 32(1):67-72. PubMed ID: 10347771
    [Abstract] [Full Text] [Related]

  • 4. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.
    Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstom RW, Fujimoto WY.
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S63-6. PubMed ID: 8894485
    [Abstract] [Full Text] [Related]

  • 5. Effects of genetic predisposition on proinsulin responses in Asian Indians.
    Ramachandran A, Snehalatha C, Satyavani K, Vijay V.
    Diabetes Res Clin Pract; 1998 Jul; 41(1):71-7. PubMed ID: 9768375
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D.
    J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
    [Abstract] [Full Text] [Related]

  • 9. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.
    Vangipurapu J, Stančáková A, Kuulasmaa T, Kuusisto J, Laakso M.
    PLoS One; 2015 May; 10(4):e0124028. PubMed ID: 25853252
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS.
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [Abstract] [Full Text] [Related]

  • 11. Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota.
    Goetz FC, French LR, Thomas W, Gingerich RL, Clements JP.
    Metabolism; 1995 Oct; 44(10):1371-6. PubMed ID: 7476300
    [Abstract] [Full Text] [Related]

  • 12. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J, Levy JC, Barrow BA, Manley SE, Turner RC.
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [Abstract] [Full Text] [Related]

  • 13. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes.
    Vauhkonen IK, Niskanen LK, Mykkänen L, Haffner SM, Uusitupa MI, Laakso M.
    Eur J Endocrinol; 2000 Aug; 143(2):251-60. PubMed ID: 10913945
    [Abstract] [Full Text] [Related]

  • 14. Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.
    Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ.
    Diabetologia; 1996 Jan; 39(1):113-8. PubMed ID: 8720611
    [Abstract] [Full Text] [Related]

  • 15. Proinsulin as a marker for the development of NIDDM in Japanese-American men.
    Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY.
    Diabetes; 1995 Feb; 44(2):173-9. PubMed ID: 7859937
    [Abstract] [Full Text] [Related]

  • 16. [The clinical significance of true insulin and proinsulin levels in subjects with different glucose tolerance].
    Yang J, Li M, Wu C.
    Zhonghua Nei Ke Za Zhi; 2000 Dec; 39(12):811-3. PubMed ID: 11798541
    [Abstract] [Full Text] [Related]

  • 17. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance.
    Shimizu M, Kawazu S, Tomono S, Ohno T, Utsugi T, Kato N, Ishi C, Ito Y, Murata K.
    Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525
    [Abstract] [Full Text] [Related]

  • 18. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.
    Larsson H, Ahrén B.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2068-74. PubMed ID: 10372712
    [Abstract] [Full Text] [Related]

  • 19. Plasma proinsulin in first-degree relatives of type 2 diabetic subjects.
    Beer SF, O'Rahilly S, Spivey RS, Hales CN, Turner RC.
    Diabetes Res; 1990 Jun; 14(2):51-4. PubMed ID: 2134213
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community.
    Costa A, Rios M, Casamitjana R, Gomis R, Conget I.
    Diabetes Res Clin Pract; 1998 Sep; 41(3):191-6. PubMed ID: 9829348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.